Literature DB >> 21820360

Future directions for epidemiology in epilepsy.

Christine Linehan1, José F Tellez-Zenteno, Jorge G Burneo, Anne T Berg.   

Abstract

Epidemiology continues to be an important research tool in the study of epilepsy and related disorders, providing a better understanding of the frequency, causes and natural history of the disorder. But, beyond risk factors and seizure prognosis, epidemiological studies advance knowledge of many other aspects of epilepsy. Epidemiological studies are being conducted in a new environment in which high quality neuroimaging and fast through-put genomic technologies have become routine tools in clinical diagnosis and therapeutics. Epilepsy is currently understood, not as a single, homogeneous disorder, but a multitude of different clinical syndromes and disease, each with its own cause(s), natural history, and treatment implications. That is why; the comorbidites of epilepsy represent an important area, amenable to study, as they may ultimately have a greater impact on quality of life than epilepsy itself. In this document we share our thoughts on what we think are the future directions for epidemiology in epilepsy.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21820360      PMCID: PMC3170446          DOI: 10.1016/j.yebeh.2011.06.006

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN: 1525-5050            Impact factor:   2.937


  40 in total

1.  De novo mutations in the sodium-channel gene SCN1A cause severe myoclonic epilepsy of infancy.

Authors:  L Claes; J Del-Favero; B Ceulemans; L Lagae; C Van Broeckhoven; P De Jonghe
Journal:  Am J Hum Genet       Date:  2001-05-15       Impact factor: 11.025

Review 2.  Serotonergic neurons as carbon dioxide sensors that maintain pH homeostasis.

Authors:  George B Richerson
Journal:  Nat Rev Neurosci       Date:  2004-06       Impact factor: 34.870

3.  Injuries in people with self-reported epilepsy: a population-based study.

Authors:  José F Téllez-Zenteno; Gary Hunter; Samuel Wiebe
Journal:  Epilepsia       Date:  2007-12-28       Impact factor: 5.864

4.  Serious psychological distress among persons with epilepsy based on the 2005 California Health Interview Survey.

Authors:  J Layne Moore; John O Elliott; Bo Lu; Emily T Klatte; Christine Charyton
Journal:  Epilepsia       Date:  2009-02-26       Impact factor: 5.864

5.  The costs of epilepsy misdiagnosis in England and Wales.

Authors:  Ariadna Juarez-Garcia; Tim Stokes; Beth Shaw; Janette Camosso-Stefinovic; Richard Baker
Journal:  Seizure       Date:  2006-09-29       Impact factor: 3.184

6.  Examining the prevalence of epilepsy and delivery of epilepsy care in Ireland.

Authors:  Christine Linehan; Mike P Kerr; Patricia N Walsh; Gerry Brady; Cecily Kelleher; Norman Delanty; Frances Dawson; Mike Glynn
Journal:  Epilepsia       Date:  2009-12-01       Impact factor: 5.864

7.  Prevalence of epilepsy and epileptic seizures in 10-year-old children: results from the Metropolitan Atlanta Developmental Disabilities Study.

Authors:  C C Murphy; E Trevathan; M Yeargin-Allsopp
Journal:  Epilepsia       Date:  1995-09       Impact factor: 5.864

8.  A population-based study of risk of epilepsy after hospitalization for traumatic brain injury.

Authors:  Pamela L Ferguson; Gigi M Smith; Braxton B Wannamaker; David J Thurman; E Elisabeth Pickelsimer; Anbesaw W Selassie
Journal:  Epilepsia       Date:  2009-10-20       Impact factor: 5.864

9.  Frequency, prognosis and surgical treatment of structural abnormalities seen with magnetic resonance imaging in childhood epilepsy.

Authors:  Anne T Berg; Gary W Mathern; Richard A Bronen; Robert K Fulbright; Francis DiMario; Francine M Testa; Susan R Levy
Journal:  Brain       Date:  2009-07-28       Impact factor: 13.501

10.  Are psychiatric disorders independent risk factors for new-onset epilepsy in older individuals?

Authors:  Alan B Ettinger; Laurel A Copeland; John E Zeber; Anne C Van Cott; Mary Jo V Pugh
Journal:  Epilepsy Behav       Date:  2009-11-12       Impact factor: 2.937

View more
  8 in total

1.  Neuroimaging in the definition and organization of the epilepsies: we're not there yet.

Authors:  Jason S Hauptman; Noriko Salamon; Gary W Mathern
Journal:  Epilepsia       Date:  2012-07       Impact factor: 5.864

2.  Mandarin functional MRI Language paradigms.

Authors:  He Ci; Andre van Graan; Gloria Gonzálvez; Pamela Thompson; Andrea Hill; John S Duncan
Journal:  Brain Behav       Date:  2016-08-03       Impact factor: 2.708

Review 3.  The causal relationship between neurocysticercosis infection and the development of epilepsy - a systematic review.

Authors:  Lucy B Gripper; Susan C Welburn
Journal:  Infect Dis Poverty       Date:  2017-04-05       Impact factor: 4.520

4.  Functional magnetic resonance imaging based on Chinese tasks to protect language function in epileptics.

Authors:  Peng Wang; Feizhou Du; Jianhao Li; Hongmei Yu; Chencheng Tang; Rui Jiang
Journal:  Brain Behav       Date:  2020-12-30       Impact factor: 3.405

5.  Epilepsy Combined With Multiple Gene Heterozygous Mutation.

Authors:  He Qiuju; Zhuang Jianlong; Wen Qi; Li Zhifa; Wang Ding; Sun Xiaofang; Xie Yingjun
Journal:  Front Pediatr       Date:  2022-03-01       Impact factor: 3.418

6.  Psychiatric disorders after epilepsy diagnosis: a population-based retrospective cohort study.

Authors:  Hsiu-Ju Chang; Chien-Chang Liao; Chaur-Jong Hu; Winston W Shen; Ta-Liang Chen
Journal:  PLoS One       Date:  2013-04-05       Impact factor: 3.240

7.  Spectrum of epilepsy - prevalence, impact, and treatment gap: an epidemiological study from Al-Quseir, Egypt.

Authors:  Hamdy N El-Tallawy; Wafaa M Farghaly; Tarek A Rageh; Ghaydaa A Shehata; Nabil A Metwally; Reda Badry; Mohammed A Sayed; Ahmed M Abdelwarith; Mahmoud R Kandil; Mohamed A Hamed; Khaled O Mohamed; Amal M Tohamy
Journal:  Neuropsychiatr Dis Treat       Date:  2016-05-12       Impact factor: 2.570

8.  A novel metabolism-based phenotypic drug discovery platform in zebrafish uncovers HDACs 1 and 3 as a potential combined anti-seizure drug target.

Authors:  Kingsley Ibhazehiebo; Cezar Gavrilovici; Cristiane L de la Hoz; Shun-Chieh Ma; Renata Rehak; Gaurav Kaushik; Paola L Meza Santoscoy; Lucas Scott; Nandan Nath; Do-Young Kim; Jong M Rho; Deborah M Kurrasch
Journal:  Brain       Date:  2018-03-01       Impact factor: 13.501

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.